Clinica Animedica
- Address
- Strada Caimetei nr.20, 021056 Bucharest, Romania
Nervous System Diseases
At Clinica Animedica, researchers are exploring new treatments for schizophrenia in adolescents, aiming to improve symptom control and safety.
- Efficacy of KarXT in teenage schizophrenia
- Safety profile of KarXT over long‑term use
The department’s focus on nervous system disorders supports innovative therapies for young patients.
Mental Disorders
The psychiatry unit is also evaluating interventions for irritability linked to autism spectrum disorder in children and teens.
- Combination therapy KarXT+KarX‑EC for ASD‑related irritability
- Comparative study of KarXT versus placebo in adolescent schizophrenia
Clinica Animedica’s commitment to mental health research drives these youth‑focused trials.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinica Animedica
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A study to evaluate the effectiveness and safety of trospium chloride and xanomeline tartrate for treating schizophrenia in adolescents aged 13 to 17 years. | Bristol-Myers Squibb Services Unlimited Company | Phase III | Recruiting | Jun 2026 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Trospium Chloride | 2 | Unknown | 2026-06-29 | 2026-06-29 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.